Lenvatinib + Pembrolizumab Treats Advanced Endometrial Cancer

MONDAY, Jan. 31, 2022 -- For patients with advanced endometrial cancer, lenvatinib plus pembrolizumab results in significantly longer progression-free and overall survival than the physician ' s choice of chemotherapy, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news